Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Oncology
49%
Minimal Residual Disease
32%
Childhood Cancer
30%
Event Free Survival
20%
T Cell
19%
Pediatrics
18%
Disease
17%
Flow Cytometry
16%
Precursor
15%
Neoplasm
14%
Malignant Neoplasm
13%
Immunophenotyping
12%
B Cell
11%
Methotrexate
11%
Overall Survival
11%
Diagnosis
10%
Leukocyte
10%
Leukemia
10%
Acute B-Cell Lymphoblastic Leukemia
10%
Acute Leukemia
10%
Hodgkin's Lymphoma
9%
Non-Hodgkin Lymphoma
9%
Group Trial
8%
Monoclonal Antibody
8%
Lymphoid Leukemia
8%
Central Nervous System
7%
Clinical Trial
7%
Epstein Barr Virus
7%
Morphology
7%
Prognostic Factor
6%
Gene Expression
5%
Acute Myeloid Leukemia
5%
Lymphocyte
5%
Keyphrases
Acute Lymphoblastic Leukemia
48%
Group Studies
36%
Pediatric Oncology
30%
Children's Oncology Group
29%
Minimal Residual Disease
24%
B-cell Acute Lymphoblastic Leukemia (B-ALL)
17%
Childhood Acute Lymphoblastic Leukemia
17%
Monoclonal Antibody
14%
Event-free Survival
14%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
12%
Leukemia
11%
Newly Diagnosed
11%
Complete Remission
9%
Immunophenotyping
9%
Older Adults
9%
T Cells
9%
Flow Cytometry
9%
Chemotherapy
8%
Oncology
8%
Childrens
8%
Non-Hodgkin Lymphoma
8%
High Risk
7%
Acute Leukemia
7%
Remission
7%
Standard Risk
6%
Overall Survival
6%
Precursor B-cell Acute Lymphoblastic Leukemia
6%
Group Experiences
6%
Leukemic Cells
6%
Lymphoma
6%
Epstein-Barr Virus
5%
Methotrexate
5%
Tumor
5%
B-precursor
5%
Pediatric Acute Lymphoblastic Leukemia
5%
Marrow
5%
B Cells
5%
Down Syndrome
5%